Physician profile
Julia Brown
NPI 1568755627
$2,075.84
in general payments reported to CMS, 2019-2025
24 companies · $64.39 in 2025
The $64.39 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $645 · 2022: $1,048 · 2023: $265 · 2024: $53.07 · 2025: $64.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $442.42 | 2021-2023 | Urolift |
| Astellas Pharma US INC | $289.60 | 2021-2023 | Myrbetriq |
| Janssen Biotech, INC. | $197.86 | 2021-2022 | |
| Myovant Sciences INC. | $159.82 | 2021-2022 | |
| Abbvie INC. | $154.48 | 2021-2023 | |
| Pfizer INC. | $128.14 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.85 | 2021-2023 | |
| Allergan, INC. | $70.34 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $69.16 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $63.64 | 2021-2023 | Provenge |
| Urovant Sciences INC | $60.14 | 2022 | |
| Convatec INC. | $48.80 | 2022 | |
| Avita Medical Americas, LLC | $48.38 | 2025 | Permeaderm, Cohealyx, Recell |
| Tolmar Pharmaceuticals, INC. | $45.43 | 2021-2022 | |
| Ethicon US, LLC | $36.53 | 2024 | Prolene |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $27.97 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $26.29 | 2022 | |
| Sumitomo Pharma America, INC. | $22.16 | 2023 | Gemtesa |
| Kci USA, INC. | $18.49 | 2023 | Abthera, Prevena, V.A.C.Ulta |
| Axonics, INC. | $18.38 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.54 | 2024 | Adstiladrin |
| Baxter Healthcare | $16.23 | 2021 | |
| Neuros Medical, INC. | $16.01 | 2025 | Altius |
| Merck Sharp & Dohme LLC | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.